| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-06 15:16:50 UTC |
|---|
| Update Date | 2022-03-07 02:51:42 UTC |
|---|
| HMDB ID | HMDB0014701 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Doxapram |
|---|
| Description | Doxapram, also known as docatone or (+-)-doxapram, belongs to the class of organic compounds known as diphenylmethanes. Diphenylmethanes are compounds containing a diphenylmethane moiety, which consists of a methane wherein two hydrogen atoms are replaced by two phenyl groups. Doxapram is a drug which is used for use as a temporary measure in hospitalized patients with acute respiratory insufficiency superimposed on chronic obstructive pulmonary disease. Based on a literature review a significant number of articles have been published on Doxapram. |
|---|
| Structure | CCN1CC(CCN2CCOCC2)C(C1=O)(C1=CC=CC=C1)C1=CC=CC=C1 InChI=1S/C24H30N2O2/c1-2-26-19-22(13-14-25-15-17-28-18-16-25)24(23(26)27,20-9-5-3-6-10-20)21-11-7-4-8-12-21/h3-12,22H,2,13-19H2,1H3 |
|---|
| Synonyms | | Value | Source |
|---|
| (+-)-Doxapram | ChEBI | | 1-Ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-2-pyrrolidinone | ChEBI | | Docatone | Kegg | | AHP brand OF doxapram hydrochloride | HMDB | | Hydrochloride, doxapram | HMDB | | Riemser brand OF doxapram hydrochloride | HMDB | | Wyeth brand OF doxapram | HMDB | | Genopharm brand OF doxapram hydrochloride | HMDB | | Antigen brand OF doxapram hydrochloride | HMDB | | Doxapram hydrochloride | HMDB | | Wyeth brand OF doxapram hydrochloride | HMDB | | Dopram | HMDB |
|
|---|
| Chemical Formula | C24H30N2O2 |
|---|
| Average Molecular Weight | 378.5072 |
|---|
| Monoisotopic Molecular Weight | 378.230728214 |
|---|
| IUPAC Name | 1-ethyl-4-[2-(morpholin-4-yl)ethyl]-3,3-diphenylpyrrolidin-2-one |
|---|
| Traditional Name | doxapram |
|---|
| CAS Registry Number | 309-29-5 |
|---|
| SMILES | CCN1CC(CCN2CCOCC2)C(C1=O)(C1=CC=CC=C1)C1=CC=CC=C1 |
|---|
| InChI Identifier | InChI=1S/C24H30N2O2/c1-2-26-19-22(13-14-25-15-17-28-18-16-25)24(23(26)27,20-9-5-3-6-10-20)21-11-7-4-8-12-21/h3-12,22H,2,13-19H2,1H3 |
|---|
| InChI Key | XFDJYSQDBULQSI-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as diphenylmethanes. Diphenylmethanes are compounds containing a diphenylmethane moiety, which consists of a methane wherein two hydrogen atoms are replaced by two phenyl groups. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Benzenoids |
|---|
| Class | Benzene and substituted derivatives |
|---|
| Sub Class | Diphenylmethanes |
|---|
| Direct Parent | Diphenylmethanes |
|---|
| Alternative Parents | |
|---|
| Substituents | - Diphenylmethane
- 3-phenylpyrrolidine
- Aralkylamine
- Morpholine
- Oxazinane
- Pyrrolidone
- 2-pyrrolidone
- N-alkylpyrrolidine
- Pyrrole
- Pyrrolidine
- Tertiary carboxylic acid amide
- Tertiary amine
- Amino acid or derivatives
- Tertiary aliphatic amine
- Carboxamide group
- Lactam
- Organoheterocyclic compound
- Oxacycle
- Azacycle
- Carboxylic acid derivative
- Dialkyl ether
- Ether
- Hydrocarbon derivative
- Organic oxygen compound
- Organonitrogen compound
- Organic nitrogen compound
- Organooxygen compound
- Organopnictogen compound
- Organic oxide
- Carbonyl group
- Amine
- Aromatic heteromonocyclic compound
|
|---|
| Molecular Framework | Aromatic heteromonocyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 0.034 g/L | Not Available | | LogP | 3.6 | Not Available |
|
|---|
| Experimental Chromatographic Properties | Experimental Collision Cross Sections| Adduct Type | Data Source | CCS Value (Å2) | Reference |
|---|
| [M+H]+ | CBM | 183.4 | 30932474 |
|
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 5.67 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 10.9104 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 2.06 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 52.8 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1541.6 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 193.3 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 184.4 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 177.3 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 106.3 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 364.1 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 400.4 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 504.1 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 831.4 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 340.9 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1211.1 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 280.9 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 315.6 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 264.1 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 341.4 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 11.7 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatized |
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Doxapram GC-MS (Non-derivatized) - 70eV, Positive | splash10-0i2c-5659000000-be23830af6d9087814ee | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Doxapram GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental LC-MS/MS | LC-MS/MS Spectrum - Doxapram , positive-QTOF | splash10-004i-0329000000-18907cc9c391c98b3b37 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Doxapram 35V, Positive-QTOF | splash10-002f-4795000000-b282c5e89dd38c3bd102 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Doxapram 10V, Positive-QTOF | splash10-004i-0019000000-7388549b90a129ecea29 | 2016-08-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Doxapram 20V, Positive-QTOF | splash10-016r-0923000000-fd4fdb00610b243a1090 | 2016-08-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Doxapram 40V, Positive-QTOF | splash10-014l-6931000000-1265933cebd94c823bf1 | 2016-08-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Doxapram 10V, Negative-QTOF | splash10-004i-0019000000-fc11ef54ebcd076d9cbc | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Doxapram 20V, Negative-QTOF | splash10-004i-1019000000-a3f15077c822e810dc4f | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Doxapram 40V, Negative-QTOF | splash10-05n0-9258000000-dae2a47b8643c6398d75 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Doxapram 10V, Positive-QTOF | splash10-004i-0009000000-bb513d4d6fc6677b2267 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Doxapram 20V, Positive-QTOF | splash10-0006-0091000000-bda540c1b6f859d2a064 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Doxapram 40V, Positive-QTOF | splash10-05mo-0295000000-a4ceb24cad9c7292389e | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Doxapram 10V, Negative-QTOF | splash10-004i-0009000000-974a448b0b2dd09672c6 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Doxapram 20V, Negative-QTOF | splash10-004j-0049000000-7bc57bde396b93d25c90 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Doxapram 40V, Negative-QTOF | splash10-000i-2964000000-1059ea9825c11e5a73cb | 2021-09-22 | Wishart Lab | View Spectrum |
|
|---|